Lactose intolerance associated with adjuvant 5-fluorouracil-based chemotherapy for colorectal cancer Pia Österlund, Tarja Ruotsalainen, Katri Peuhkuri, Riitta Korpela, Anneli Ollus, Minna Ikonen, Heikki Joensuu, Inkeri Elomaa Clinical Gastroenterology and Hepatology Volume 2, Issue 8, Pages 696-703 (August 2004) DOI: 10.1016/S1542-3565(04)00293-9
Figure 1 Numbers of patients with colorectal cancer with abnormal, borderline, or normal lactose absorption test results before, during, and after adjuvant chemotherapy. Bolus, the Mayo regimen; continuous, the modified de Gramont regimen; chemotherapy only, chemotherapy without radiotherapy; chemoradiation, chemotherapy plus radiotherapy to the pelvis. P for Wilcoxon’s signed rank test for hypolactasia comparison before vs. during chemotherapy. Clinical Gastroenterology and Hepatology 2004 2, 696-703DOI: (10.1016/S1542-3565(04)00293-9)